Table S7 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma
Year: 2026
Type: other
Abstract: EnhancerPromoter ChIP AUC output for IRF4, p300, and H3K27ac in MM1.S, as well as other omic metrics used for heatmap within Figure 3E.
Authors: W. Frank Lenoir, Michael R. McKeown, Giulia Giorgetti, Marek J. Kobylarz, Tamara D. Hopkins, Wayne L. Glore, Michelle G. Shum, Yaretzi Calderón, Jessica Encinas Mayoral, Luis A. Carvajal, Kameron R. Mori, Jun Li, Hua Gao, Yupeng Zheng, Zhihua Ma, Nikolaus D. Obholzer, Minyun Zhou, Benjamin W. Trotter, Christopher J. Dinsmore, Nikhil C. Munshi, Charles Y. Lin, Mariateresa Fulciniti, Peter B. Rahl
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7130609738